Efficacy and safety of BORTEZOMIB treatment for refractory acute antibody-mediated rejection-a pilot study. [electronic resource]
Producer: 20190821Description: 47-50 p. digitalISSN:- 2059-2310
- Adrenal Cortex Hormones -- therapeutic use
- Adult
- Bortezomib -- therapeutic use
- Drug Administration Schedule
- Female
- Graft Rejection -- blood
- Graft Survival
- HLA Antigens -- genetics
- Histocompatibility Testing -- methods
- Humans
- Immunologic Factors -- therapeutic use
- Isoantibodies -- blood
- Kidney Transplantation
- Male
- Middle Aged
- Patient Safety
- Pilot Projects
- Plasmapheresis -- methods
- Prognosis
- Rituximab -- therapeutic use
- Tissue Donors
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.